IGWM
VXRT

ICA Group Wealth Management’s Vaxart VXRT Stock Holding History

ICA Group Wealth Management’s Portfolio VXRT Stock Details VXRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-50
Closed -$36 – 1221
2023
Q2 		$36 Hold
50
– – ﹤0.01% 1327
2023
Q1 		$38 Hold
50
– – ﹤0.01% 1266
2022
Q4 		$54 Buy
+50
New +$71 ﹤0.01% 1307

Other funds holding VXRT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
CSS
Cubist Systematic Strategies Stamford, Connecticut $21B AUM 21.48% 1-Year Est. Return

ICA Group Wealth Management's VXRT Position: Q3 2023 in Review

ICA Group Wealth Management sold out of Vaxart (VXRT) in Q3 2023, closing a stake of 50 shares — an estimated $36 sold.

ICA Group Wealth Management first reported a position in VXRT in Q4 2022 and held it in 3 quarters. The position peaked at $54 in Q4 2022. 96 funds tracked by Wall St. Rank hold VXRT as of Q3 2023.

  • ICA Group Wealth Management reported no remaining Vaxart position as of Q3 2023 after selling out during the quarter.
  • ICA Group Wealth Management sold 50 Vaxart shares in Q3 2023, an estimated $36.
  • ICA Group Wealth Management first reported a position in Vaxart in Q4 2022 and held it in 3 quarters.
  • ICA Group Wealth Management's Vaxart position peaked at $54 in Q4 2022.
  • 96 funds tracked by Wall St. Rank held Vaxart as of Q3 2023.

Based on ICA Group Wealth Management's 13F filing for Q3 2023, filed 13 Nov 2023.